Glioblastoma: Changing concepts in the WHO CNS5 classification
Glioblastoma is the most common malignant central nervous system (CNS) tumor in adults. Acute common clinical symptoms include headache, seizure, behavior changes, focal neurological deficits, and signs of increased intracranial pressure. The classic MRI finding of glioblastoma is an irregularly sha...
Main Authors: | Jie Chen, Pengcheng Han, Sonika Dahiya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=5;spage=24;epage=32;aulast=Chen |
Similar Items
-
Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5
by: Ahmad Z, et al.
Published: (2023-01-01) -
Impact of new molecular criteria on diagnosis and survival of adult glioma patients
by: Danny Mortensen, et al.
Published: (2022-12-01) -
Imaging the WHO 2021 Brain Tumor Classification: Fully Automated Analysis of Imaging Features of Newly Diagnosed Gliomas
by: Michael Griessmair, et al.
Published: (2023-04-01) -
Clinical roles of EGFR amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumors
by: Hai Wang, et al.
Published: (2024-02-01) -
Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
by: Yaning Wang, et al.
Published: (2023-06-01)